Literature DB >> 1908616

Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin.

A H Conney1, T Lysz, T Ferraro, T F Abidi, P S Manchand, J D Laskin, M T Huang.   

Abstract

Topical application of curcumin, the major yellow pigment in turmeric and curry, has a potent inhibitory effect on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced tumor promotion in mouse skin. The structurally related compounds chlorogenic acid, caffeic acid and ferulic acid are less potent inhibitors. Curcumin is a potent inhibitor of TPA-induced ornithine decarboxylase activity and inflammation in mouse skin whereas chlorogenic acid, caffeic acid and ferulic acid are only weakly active or inactive. Curcumin is a potent inhibitor of arachidonic acid-induced inflammation in vivo in mouse skin, and this compound is also a potent inhibitor of epidermal lipoxygenase and cyclooxygenase activity in vitro. Although chlorogenic acid is only weakly active as an inhibitor of epidermal lipoxygenase activity and TPA-induced ear inflammation, it is more active than caffeic acid and ferulic acid. The inhibitory effects of curcumin, chlorogenic acid, caffeic acid and ferulic acid on TPA-induced tumor promotion in mouse skin parallel their inhibitory effects on TPA-induced epidermal inflammation and epidermal lipoxygenase and cyclooxygenase activities. Examination of the structural features of curcumin required for its biological activity indicate that free hydroxyl groups on the benzene rings are not required for inhibition of TPA-induced ornithine decarboxylase activity and inflammation in mouse skin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908616     DOI: 10.1016/0065-2571(91)90025-h

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  21 in total

Review 1.  Wnt pathway antagonists and angiogenesis.

Authors:  Bin Zhang; Jian-Xing Ma
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

2.  Effects of curcumin (diferuloylmethane) on Eimeria tenella sporozoites in vitro.

Authors:  Reda E Khalafalla; Uwe Müller; Md Shahiduzzaman; Viktor Dyachenko; Abdelrazik Y Desouky; Gottfried Alber; Arwid Daugschies
Journal:  Parasitol Res       Date:  2010-10-30       Impact factor: 2.289

3.  Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer.

Authors:  Mi-Kyung Kim; Kidong Kim; Jae Yong Han; Jeong Mook Lim; Yong Sang Song
Journal:  Genes Nutr       Date:  2011-02-04       Impact factor: 5.523

4.  Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase.

Authors:  Madesh Belakavadi; Bharathi P Salimath
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

5.  Curcumin is an in vivo inhibitor of angiogenesis.

Authors:  J L Arbiser; N Klauber; R Rohan; R van Leeuwen; M T Huang; C Fisher; E Flynn; H R Byers
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

6.  Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis.

Authors:  Ying Wang; Arun K Rishi; Wenjuan Wu; Lisa Polin; Sunita Sharma; Edi Levi; Steven Albelda; Harvey I Pass; Anil Wali
Journal:  Mol Cell Biochem       Date:  2011-05-19       Impact factor: 3.396

7.  Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates.

Authors:  D V Rajakumar; M N Rao
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

Review 8.  Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues.

Authors:  Paola Venditti; Lisa Di Stefano; Sergio Di Meo
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

9.  Examining the genomic influence of skin antioxidants in vitro.

Authors:  James V Gruber; Robert Holtz
Journal:  Mediators Inflamm       Date:  2010-07-12       Impact factor: 4.711

10.  Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects.

Authors:  Shaiju K Vareed; Madhuri Kakarala; Mack T Ruffin; James A Crowell; Daniel P Normolle; Zora Djuric; Dean E Brenner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.